Document Detail


Single and serial measurements of cardiac troponin I in asymptomatic patients on chronic hemodialysis.
MedLine Citation:
PMID:  14964456     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: Coronary artery disease is the major cause of death in patients with end-stage renal failure on dialysis. This study aimed to assess the predictive value of a single cardiac troponin I (cTnI), and also the kinetics of serial values. METHODS: Since cTnI is a potential biomarker of cardiac outcome, the present study examined single cTnI measurements (n = 88 patients) and its predictive value for future cardiac events, and a kinetic substudy of serial weekly cTnI measured for 8 weeks (n = 57) in a group of patients on hemodialysis. RESULTS: Single cTnI measurements: 9 patients (10.2%) had a detectable cTnI at baseline and 79 patients (89.8%) had a negative baseline cTnI. There were no significant differences in age, sex, history of ischemic heart disease, diabetes, smoking or dyslipidemia between patients with detectable and negative cTnI. At the end of 9 months, the rate of combined primary endpoints, which included myocardial infarction, cardiac death and cardiac revascularization, was significantly higher in the patients with a detectable baseline cTnI (55.6%), compared to patients with a negative cTnI (6.3%) (p = 0.0007). Serial weekly cTnI measurements: significant fluctuations in cTnI were noted over time; 27% of patients with an undetectable cTnI measured at baseline had subsequent detectable levels in the serial follow-up. CONCLUSION: A single detectable cTnI in asymptomatic patients on hemodialysis defines patients at high risk of future cardiac events. However, the incidence of detectable cTnI levels is markedly increased when serial weekly measurements are performed. The clinical significance of detectable serial measurements of cTnI is the focus of ongoing studies.
Authors:
M A Roberts; D Fernando; N Macmillan; G Proimos; L A Bach; D A Power; S Ratnaike; F L Ierino
Related Documents :
4051836 - Cardiac side effects of phenytoin and carbamazepine. a dose-related phenomenon?
9149586 - Noninvasive measurement of cardiac output by an acetylene uptake technique and simultan...
14759446 - Effects of hypertonic saline-dextran solution in cardiac valve surgery with cardiopulmo...
7137926 - The cardiovascular laboratory at the singapore general hospital, 1964-1981.
11677876 - Diagnostic value of apparent diffusion coefficient hyperintensity in selected patients ...
20617086 - What determines the laterality of the chronic subdural hematoma?
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical nephrology     Volume:  61     ISSN:  0301-0430     ISO Abbreviation:  Clin. Nephrol.     Publication Date:  2004 Jan 
Date Detail:
Created Date:  2004-02-13     Completed Date:  2004-06-21     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0364441     Medline TA:  Clin Nephrol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  40-6     Citation Subset:  IM    
Affiliation:
Department of Nephrology, Austin Health, Heidelberg, Victoria, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Coronary Artery Disease / diagnosis,  etiology
Female
Humans
Male
Middle Aged
Predictive Value of Tests
Renal Dialysis* / adverse effects
Troponin I / analysis*
Chemical
Reg. No./Substance:
0/Troponin I

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Differential expression of beta-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in ...
Next Document:  Efficacy of reteplase in poorly functioning hemodialysis catheters.